A DECADE OF ARVINAS
A DECADE OF ARVINAS
Forging New Scientific Frontiers in Drug Discovery
2023 marked a monumental milestone in Arvinas’ history as we celebrated our 10-year anniversary.
Over the past decade, Arvinas has made incredible strides in pioneering targeted protein degradation research.
From initiating the first oral PROTAC protein degrader clinical trials, to the initiation of Phase 3 clinical studies, we’ve remained committed to pushing the boundaries of what’s possible in biotech.




Team Arvinas: Stories of Discovery and Impact
We are incredibly proud of the milestones we have achieved thus far. But don’t just take our word for it— hear firsthand from Arvinas colleagues as they reflect on our remarkable journey.
